Relative rates not relative risks: addressing a widespread misinterpretation of hazard ratios

被引:74
作者
Sutradhar, Rinku [1 ,2 ,3 ]
Austin, Peter C. [1 ,2 ]
机构
[1] Inst Clin Evaluat Sci, G1-06 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada
[2] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[3] Univ Toronto, Dalla Lana Sch Publ Hlth, Dept Biostat, Toronto, ON, Canada
关键词
Hazard ratio; Instantaneous rate; Relative rate; Relative risk; Cox proportional hazards regression model; DIABETES TREATMENTS; COLORECTAL-CANCER; SURVIVAL; FAILURE; ODDS; DISEASE; MODELS; COHORT; IMPACT;
D O I
10.1016/j.annepidem.2017.10.014
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The use of the Cox proportional hazards model is ubiquitous in modern medical research. Despite the widespread implementation of this model, the terminology and interpretation that is used to describe the estimate hazard ratio (HR) has become loose and, unfortunately, often incorrect. Although some journals offer guidelines that advise against reporting HRs as relative risks, these guidelines are frequently overlooked. Perhaps due to a lack of understanding, authors continue to interpret the resultant HR as a relative risk such an interpretation is inappropriate and can be misleading. The HR should be described as a relative rate, not as a relative risk. This article demonstrates that although the direction of the HR can be used to explain the direction of the relative risk, the magnitude of the HR alone cannot be used to explain the magnitude of the relative risk. This article clarifies the relationship between HRs and relative risks in a way that may be better suited for the applied clinical researcher. We also provide a convenient table illustrating the magnitude of relative risk under various values of the HR; the table demonstrates that for a given constant HR, the magnitude of the relative risk can vary substantially. As a take-home message, authors should refrain from using the magnitude of the HR to describe the magnitude of the relative risk. Authors should be strongly encouraged to ascribe accurate interpretations to the statistics derived from fitted Cox proportional hazards regression models. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:54 / 57
页数:4
相关论文
共 29 条
  • [11] Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults
    Emdin, Connor A.
    Anderson, Simon G.
    Callender, Thomas
    Conrad, Nathalie
    Salimi-Khorshidi, Gholamreza
    Mohseni, Hamid
    Woodward, Mark
    Rahimi, Kazem
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
  • [12] Greenland S, 1996, EPIDEMIOLOGY, V7, P498, DOI 10.1097/00001648-199609000-00007
  • [13] Structural accelerated failure time models for survival analysis in studies with time-varying treatments
    Hernán, MA
    Cole, SR
    Margolick, J
    Cohen, M
    Robins, JM
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (07) : 477 - 491
  • [14] The Hazards of Hazard Ratios
    Hernan, Miguel A.
    [J]. EPIDEMIOLOGY, 2010, 21 (01) : 13 - 15
  • [15] Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care
    Hippisley-Cox, Julia
    Coupland, Carol
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [16] Diabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia: open cohort study in primary care
    Hippisley-Cox, Julia
    Coupland, Carol
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2016, 352
  • [17] Occupational and leisure time physical activity: risk of all-cause mortality and myocardial infarction in the Copenhagen City Heart Study. A prospective cohort study
    Holtermann, Andreas
    Marott, Jacob Louis
    Gyntelberg, Finn
    Sogaard, Karen
    Suadicani, Poul
    Mortensen, Ole S.
    Prescott, Eva
    Schnohr, Peter
    [J]. BMJ OPEN, 2012, 2 (01):
  • [18] Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio:: Which variable determines survival of cervical cancer patients?
    Jordanova, Ekaterina S.
    Gorter, Arko
    Ayachi, Ouissarn
    Prins, Frans
    Durrant, Lindy G.
    Kenter, Gerrima G.
    van der Burg, Sjoerd H.
    Fleuren, Gert Jan
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (07) : 2028 - 2035
  • [19] Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
    Khera, Amit V.
    Emdin, Connor A.
    Drake, Isabel
    Natarajan, Pradeep
    Bick, Alexander G.
    Cook, Nancy R.
    Chasman, Daniel I.
    Baber, Usman
    Mehran, Roxana
    Rader, Daniel J.
    Fuster, Valentin
    Boerwinkle, Eric
    Melander, Olle
    Orho-Melander, Marju
    Ridker, Paul M.
    Kathiresan, Sekar
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (24) : 2349 - 2358
  • [20] Survival methods - Additional topics
    Oakes, David
    Peterson, Derick R.
    [J]. CIRCULATION, 2008, 117 (22) : 2949 - 2955